Dr. Tom Marsilje was a 20-year oncology drug discovery scientist, including being a co-inventor of the non-small cell lung cancer drug “ceritinib.” He was a co-author on 25 scientific publications and was co-inventor of 19 Issued US Patents.
He was diagnosed with colorectal cancer (CRC) in 2012, and quickly realized that he had a unique viewpoint as both a Stage IV patient and as an oncology drug discovery scientist.… Read more